Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Ramelteon

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Active Not Recruiting1
Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05618002Active Not Recruiting

Lemborexant vs Clonidine vs Sedatives to Treat Insomnia in Chronic Pain Patients

NCT06797570Not ApplicableNot Yet Recruiting

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

NCT00622427Phase 4CompletedPrimary

Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia

Showing all 3 trials

Research Network

Common Treatments

  • Ramelteon1
  • Communication Strategy For Side Effect Counseling In Adhd Treatment1

Active Sponsors

  • Salem Anaesthesia Pain Clinic1
  • St. Antonius Hospital1
  • University of Alabama at Birmingham1
  • Takeda1

Top Investigators

Related Conditions

  • Attention Deficit Disorder With Hyperactivity1
  • Substance Abuse1
  • Tremor1
  • Mood Disorders1
  • Add1

Activity Timeline